Sjogren's Syndrome Market

Future Market Insights

Key Insight

The sjogren's syndrome market is projected to grow from USD 178.5 billion in 2025 to USD 239.9 billion by 2035, at a CAGR of 3.0%. Primary Sjogren’s Syndrome will dominate with a 58.7% market share, while hospitals clinics will lead the distribution channel segment with a 29.6% share.

September 13, 2025

Anurag Sharma

250 Pages

Cite this Report

Sjogren's Syndrome Market

https://www.futuremarketinsights.com/reports/sjogrens-syndrome-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Advanz Pharma Corp. Limited
Daiichi Sankyo Company
Horizon Therapeutics
MorphoSys
Novartis
Resolve Therapeutics

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Sjogren's Syndrome Market

Key Players

Similar Industry Reports